MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$1,172K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Stock-based compensation
Proceeds from related party loan
Decrease (increase) in trade rec...
Others
Negative Cash Flow Breakdown
Net loss
Loss (income) from change in fai...
Cash used in purchase of subsidi...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revaluation of contingent consideration
0
0
-34
-46
Loss from sale and disposal of fixed assets, net
0
0
-40
0
Net loss
-3,846
-19,140
-13,337
-22,862
Depreciation
5
0
1,153
1,241
Stock-based compensation
3,987
-1,928
298
438
Gain from early lease termination
-
-
2,949
-
Finance income, net
3
-385
10
-19
Loss (income) from change in fair value of liability-classified warrants
1,598
-14,056
4,429
-730
Day one loss upon entering transaction
0
5,226
-
-
Private placement warrants issuance cost
0
186
0
0
Gain from deconsolidation of subsidiary
0
1,860
-
-
Ipr&d impairment
-
-
11,842
-
Changes in balance of severance pay fund
-1
-
-
-
Other long-lived asset impairment
-
-
1,653
-
Decrease (increase) in trade receivables
-511
-
-
-
Other current assets
7
1,412
-491
-1,752
Trade accounts payable
148
274
1,612
-668
Changes in contract liability
-
-
0
0
Other accounts payable and current portion of lease liabilities
-371
-1,201
-597
-429
Goodwill impairment
-
-
0
0
Net change in operating leases
3
0
-119
42
Net cash used in operating activities
-1,170
-5,414
-4,386
-7,183
Investment in short term securities - net
176
-
-
-
Cash used in purchase of subsidiaries, net
378
-
-
-
Purchase of property and equipment
-
-
0
2
Decrease in cash as a result of deconsolidation of subsidiary
0
996
-
-
Proceeds from sale of property and equipment
-
0
1
0
Purchase of fixed assets
2
-
-
-
Cash and restricted cash acquired from the apt acquisition
-
-
0
0
Proceeds from sale of property and equipment
0
-
-
-
Net cash provided by (used in) investing activities
-556
-996
1
-2
Issuance of common stock under february 2025 spa
0
0
0
0
February 2025 spa issuance costs
0
0
0
0
Issuance of common warrants under february 2025 spa
0
0
0
0
Issuance of common stock under inducement letter agreements
-
-
0
0
Issuance of common stock under inducement letter agreements
0
0
1,251
54
Pre-funded warrants and common warrants exercise
0
-
0
0
Proceeds from related party loan
656
-
-
-
Proceeds from issuance of preferred share and warrants under january 2026 private placement, net of issuance costs
-1
2,623
0
0
Issuance of redeemable convertible preferred shares under march 2024 pipe
-
-
0
0
March 2024 pipe issuance costs
-
-
0
0
Short-term bank credit
7
-
-
-
Issuance cost from the apt acquisition
-
-
-
0
Issuance of common stock under at the market sales agreement, net of 39 issuance costs
291
-
-
-
Repayment of long-term loans
48
-
0
0
Net cash provided by financing activities
905
2,623
1,251
54
Increase (decrease) in cash, cash equivalents and restricted cash
-
-3,787
-
-
Increase (decrease) in cash, cash equivalents and restricted cash
-821
-3,787
-3,134
-7,131
Effect of exchange rate changes on cash
-
-
-
53
Cash, cash equivalents and restricted cash at beginning of period
8,069
8,069
-
17,975
Cash, cash equivalents and restricted cash at end of period
347
-
-
-
Cash and cash equivalents
347
-
-
-
Total cash and cash equivalents and restricted cash
347
1,168
-
8,069
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from related
party loan
$656K
Issuance of common stock
under at the market...
$291K
Short-term bank credit
$7K
Net cash provided by
financing activities
$905K
(-92.38%↓ Y/Y)
Canceled cashflow
$49K
Increase (decrease) in
cash, cash...
-$821K
(70.97%↑ Y/Y)
Canceled cashflow
$905K
Stock-based compensation
$3,987K
(194.24%↑ Y/Y)
Decrease (increase) in
trade receivables
-$511K
Trade accounts
payable
$148K
(-49.66%↓ Y/Y)
Depreciation
$5K
(-99.05%↓ Y/Y)
Net change in
operating leases
$3K
(0.00%↑ Y/Y)
Changes in balance of
severance pay fund
-$1K
Repayment of long-term
loans
$48K
Proceeds from issuance of
preferred share and...
-$1K
Net cash used in
operating activities
-$1,170K
(92.11%↑ Y/Y)
Canceled cashflow
$4,655K
Net cash provided by
(used in) investing...
-$556K
(-610.09%↓ Y/Y)
Net loss
-$3,846K
(71.92%↑ Y/Y)
Loss (income) from
change in fair value of...
$1,598K
(-33.75%↓ Y/Y)
Other accounts
payable and current...
-$371K
(84.57%↑ Y/Y)
Other current assets
$7K
(100.64%↑ Y/Y)
Finance income, net
$3K
(101.21%↑ Y/Y)
Cash used in purchase
of subsidiaries,...
$378K
Investment in short term
securities - net
$176K
Purchase of fixed assets
$2K
Buy us a coffee
BiomX Inc. (PHGE)
BiomX Inc. (PHGE)